BusinessWeek Logo
Analyst Picks & Pans November 27, 2009, 1:24PM EST

Picks of the Week: Microsoft, H-P, Goldman, TiVo

Wall Street analysts give their buy, sell, or hold views on various stocks in the news this week

Notable Wall Street analyst opinions on stocks in the news for the week of Nov. 23-27:

Nov. 27

QLT Inc. (QLTI)

RBC Capital upgrades to outperform from sector perform; raises price target

RBC Capital analyst Douglas Miehm said on Nov. 27 that QLT reached a settlement with Massachusetts General Hospital (MGH) in its litigation over royalties for its Visudyne treatment for wet age related macular degeneration;; the company will pay MGH $20 million for full payment of all past and future royalty obligations. Miehm said the settlement was much better than he expected.

To account for the better-than-expected settlement, Miehm narrowed his 26 cents 2011 loss per share estimate to a 24 cents loss. He upgraded the shares as he believes they are being undervalued by the market. He raised his price target to $6.00 from $4.50.

Theravance Inc. (THRX)

Cowen & Co. maintains neutral

Cowen analyst Ian Sanderson said on Nov. 27 that the FDA review deadline for the company's Vibativ compound for treatment of nosocomial pneumonia (NP) was Nov. 26; he and other Wall Street analysts see an approval delay -- likely in form of a complete-response letter. Sanderson said the key regulatory hurdle may be numerically higher mortality rates for Vibativ vs. vancomycin in Phase III trials. He sees approval for Viative for treatment of NP in the second half of 2010.

The analyst noted that with slow rollout in complicated skin and skin structure infections indication projected for Vibativ, low visibility in terms of timing, and the outcome of the anti-infective advisory committee review of the NP indication, he keeps his neutral rating on the shares.

Nov. 25

Microsoft (MSFT)

Collins Stewart rates buy

Jefferies & Co. rates buy

Credit Suisse rates outperform

Analysts cautioned on Nov. 25 not to read too much into the coming departure of Microsoft Corp. finance chief Chris Liddell, which was announced the previous day.

Liddell joined Microsoft in 2005, and this year led an effort to cut $3 billion from the company's costs amid the recession. The plan included Microsoft's first mass layoffs. Liddell will step down as CFO on Dec. 1 and be replaced by Peter Klein, Microsoft said. Klein, 47, joined Microsoft in 2002 and currently is responsible for the books at the division that produces Microsoft Office and other business programs.

Collins Stewart analyst Sandeep Aggarwal in a note to investors said Liddell "has done a great job at Microsoft for the past four and half years and he now wants to take a 'CEO type' of role."

Katherine Egbert, an analyst at Jefferies & Co., also said she thinks Liddell wants to move into a CEO role. "We don't believe Mr. Liddell was forced out, nor do we think he is leaving under untoward circumstances," she wrote in a note to investors. Egbert said Klein seems a "competent replacement" for Liddell.

Credit Suisse analyst Philip Winslow said he is "encouraged by Microsoft's selection to replace Chris Liddell and believe that Peter Klein's track record suggests he will continue the focus on cost efficiency championed by Liddell."

TiVo Inc. (TIVO)

Standard & Poor's Equity Research maintains buy

S&P equity analyst Tuna Amobi said on Nov. 25 that TiVo's October-quarter operating loss per share of 6 cents, which compared with a year earlier loss of one cent, matched his estimate. He noted worse-than-projected subscriber losses, with other "lackluster" metrics, as TiVo guided expectations for January-quarter results to a $5 million-$7 million adjusted EBITDA loss and a $13 million-$15 million net loss.

Amobi sees further crucial traction on distribution and audience measurement, underscored by TiVo's latest pacts with Virgin Media (VMED) and Google Google (GOOG), among key strategic partnerships with potential long term upside.

With an imminent ruling on the company's litigation with Dish Network Corp. (DISH) viewed as pivotal to TiVo's patent momentum, the analyst keep his $14 price target.

Reader Discussion

 

BW Mall - Sponsored Links

Buy a link now!